期刊文献+

Increased level of glycated hemoglobin portends high risk of coronary artery stenosis

Increased level of glycated hemoglobin portends high risk of coronary artery stenosis
原文传递
导出
摘要 Background Increased level of glycated hemoglobin (HbAlc) is associated with higher incidence of coronary artery disease (CAD) in the diabetics. However, the relationship between HbAlc and the risk of coronary artery stenosis in the non-diabetics is controversial. Methods A retrospective research was conducted on 338 enrolled participants who have undergone 2 times of coronary angiographic examination within the past year. Clinical and laboratory variables at the initial and the second time of admission were collected. According to the initial median HbAlc level, all participants were divided into two groups named lower and higher groups. The relationship between HbAlc level and the risk of coronary artery stenosis over time was evaluated. Results The initial values of HbAlc in lower and upper groups were 5.78 ± 0.35% and 6.21 ± 0.32% (P 〈 0.05). As compared to the lower group, the percentages of male and smoking participants, and the serum level of CRP were significantly higher in the higher group (P 〈 0.05). Other traditional risk factors were comparable between the two groups. There were 54.2% and 55.2% participants with single vessel stenosis, and 45.8% and 44.8% with multiple vessel stenoses, respectively in the two groups without significant difference. The second time of admission, were 308.5 ± 25.4 days (lower group) and 300.7 ± 30.1 days (higher group) from the initial admission. Although no significant changes of HbAlc level were observed when compared to initial, HbAlc level in the higher group was still significantly higher in comparison to the lower group (6.24 ±0.39% vs. 5.80 ± 0.36%, P = 0.008). The percentage of new coronary artery stenosis (≥ 50% stenosis) was higher in the higher group than that in the lower group (41.7% vs. 32.3%, P 〈 0.001). Multivariate regression analyses suggested that HbAlc remained independent factor associated with coronary artery stenoses after extensive adjustment for risk factors. Conclusion In the nondiabetics, increased baseline HbAlc level portends the risk of coronary atherosclerotic plaque progression over time. Background Increased level of glycated hemoglobin (HbAlc) is associated with higher incidence of coronary artery disease (CAD) in the diabetics. However, the relationship between HbAlc and the risk of coronary artery stenosis in the non-diabetics is controversial. Methods A retrospective research was conducted on 338 enrolled participants who have undergone 2 times of coronary angiographic examination within the past year. Clinical and laboratory variables at the initial and the second time of admission were collected. According to the initial median HbAlc level, all participants were divided into two groups named lower and higher groups. The relationship between HbAlc level and the risk of coronary artery stenosis over time was evaluated. Results The initial values of HbAlc in lower and upper groups were 5.78 ± 0.35% and 6.21 ± 0.32% (P 〈 0.05). As compared to the lower group, the percentages of male and smoking participants, and the serum level of CRP were significantly higher in the higher group (P 〈 0.05). Other traditional risk factors were comparable between the two groups. There were 54.2% and 55.2% participants with single vessel stenosis, and 45.8% and 44.8% with multiple vessel stenoses, respectively in the two groups without significant difference. The second time of admission, were 308.5 ± 25.4 days (lower group) and 300.7 ± 30.1 days (higher group) from the initial admission. Although no significant changes of HbAlc level were observed when compared to initial, HbAlc level in the higher group was still significantly higher in comparison to the lower group (6.24 ±0.39% vs. 5.80 ± 0.36%, P = 0.008). The percentage of new coronary artery stenosis (≥ 50% stenosis) was higher in the higher group than that in the lower group (41.7% vs. 32.3%, P 〈 0.001). Multivariate regression analyses suggested that HbAlc remained independent factor associated with coronary artery stenoses after extensive adjustment for risk factors. Conclusion In the nondiabetics, increased baseline HbAlc level portends the risk of coronary atherosclerotic plaque progression over time.
出处 《South China Journal of Cardiology》 CAS 2016年第1期24-30,共7页 岭南心血管病杂志(英文版)
关键词 glycated hemoglobin coronary artery disease non-diabetics glycated hemoglobin coronary artery disease non-diabetics
  • 相关文献

参考文献18

  • 1Larun L, Bj0mer T, Fretheim A, et al. Tidsskr Nor Laege-foren 2016,136:417-422.
  • 2Uccioli L, Gandini R, Giurato L, et al. Long - term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabetes Care 2010,33: 977-982.
  • 3Selvin E,Steffes MW, Zhu H,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N EnglJ Med 2010, 362: 800-811.
  • 4Ashraf H, Boroumand MA, Amirzadegan A, et al. Hemoglobin A 1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity. Diabetes Res Clin Pract 2013,102: 225-232.
  • 5Selvin E, Steffes MW, Gregg E,et al. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011’ 34: 84-89.
  • 6Garg N,Moorthy N, Kapoor A, et al. Hemoglobin A(lc) in nondiabetic patients: an independent predictor of coronary artery disease and its severity. Mayo Clin Proc 2014, 89: 908-916.
  • 7Cai A, Li G, Chen J, et al. Glycated hemoglobin level issignificantly associated with the severity of coronary artery disease in non - diabetic adults. Lipids Health Dis 2014,13: 181.
  • 8Selvin E, Crainiceanu CM, Brancati FL, et al. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007, 167: 1545-1551.
  • 9Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010, 33: 101-103.
  • 10Diedrichs H, Pfister R,Clement Z,et al. Delta-glycated hemoglobin: a novel independent risk factor for cardiovascular events in patients without diabetes mellitus. J Endocrinol Invest 2009’ 32: 564-567.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部